BridgeMD
New treatment option for Hypothyroidism
Official title SNUH Immune Checkpoint Inhibitor-induced Hypothyroidism Recovery Trial
ClinicalTrials.gov ID: NCT07421869
What this study is testing
What is Levothyroxine tapering?
Levothyroxine tapering is an investigational medicine, being studied as a potential treatment for hypothyroidism.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this study is to find out whether hypothyroidism caused by immune checkpoint inhibitors (ICIs) can recover after stopping the ICIs. The study also aims to identify factors that can help predict which patients will be able to stop taking thyroid hormone replacement.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 and older
You may be able to join if
- Adults aged 19 years or older.
- Patients with a history of treatment with immune checkpoint inhibitors (ICIs).
- Developed hypothyroidism during ICI treatment and initiated levothyroxine after starting ICI therapy.
- Discontinued ICI therapy prior to study enrollment.
You likely can't join if
- Use of levothyroxine or antithyroid medications within 3 months prior to initiating ICI therapy.
- History of thyroid surgery, radioactive iodine therapy, or neck radiation therapy.
- Current levothyroxine dose ≥0.1 mg at the time of enrollment.
The study team makes the final eligibility decision.
Where it's taking place
- Seongnam-si, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seongnam-si, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.